Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03605966 · ClinicalTrials.gov registry record
Developing a Method to Objectively Measure Opioid Analgesia
A clinical trial of Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use, sponsored by Julia Finkel.
- Active
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT03605966 is a study of Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use that is active but no longer recruiting, run by Julia Finkel. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03605966, a study of Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use, is active but no longer recruiting, sponsored by Julia Finkel.
- ACTIVE NOT RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Inappropriate prescribing is the fundamental upstream driver of the opioid epidemic. Objective measures to determine the appropriateness of an opioid intervention, provide monitoring of the therapy for adequacy of dose and detection of tolerance or hyperalgesia would eliminate the subjective nature of opioid mediated pain management and obviate iatrogenic facilitation of opioid abuse. The present study is designed to objectively determine whether our device can pain type and determine analgesic efficacy thereby optimizing treatment selection and opioid management.
Conditions Studied
Study Locations (1)
District of Columbia
- Children's National Health System - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2025-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03605966
The ClinicalTrials.gov registry entry for NCT03605966 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Julia Finkel, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use appearing as the primary indexed condition, and to 0 interventions.
NCT03605966 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03605966 about?
NCT03605966 is a clinical study titled "Developing a Method to Objectively Measure Opioid Analgesia". Inappropriate prescribing is the fundamental upstream driver of the opioid epidemic. Objective measures to determine the appropriateness of an opioid intervention, provide monitoring of the therapy for adequacy of dose and detection of tolerance or hyperalgesia would eliminate the subjective nature ...
What is the current status of trial NCT03605966?
This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2018-07-01. Estimated completion is 2025-12-01.
What conditions does trial NCT03605966 study?
This clinical trial studies the following conditions: Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use.
Who is sponsoring clinical trial NCT03605966?
This trial is sponsored by Julia Finkel, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03605966 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Analgesics, Antipyretics and Anti-Inflammatory Drugs Causing Adverse Effects in Therapeutic Use
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.